Evaluating the innovative potential of the global antibacterial pipeline
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference46 articles.
1. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis;Tacconelli;Lancet Infect Dis,2018
2. Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed;Butler;Antimicrob Agents Chemother,2022
3. Analysis of the clinical antibacterial and antituberculosis pipeline;Theuretzbacher;Lancet Infect Dis,2019
4. Role of new antibiotics for KPC-producing Klebsiella pneumoniae;Theuretzbacher;J Antimicrob Chemother,2021
5. Ceftazidime is the key diversification and selection driver of VIM-type carbapenemases;Martínez-García;mBio,2018
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Challenges and strategies for addressing antibacterial drug resistance in LMICs;Nature Reviews Microbiology;2024-09-13
2. Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance;The Lancet;2024-06
3. New antibiotics to combat One Health AMR;Microbiology Australia;2024-05-23
4. Iron‐doped nanozymes with spontaneous peroxidase‐mimic activity as a promising antibacterial therapy for bacterial keratitis;Smart Medicine;2024-05-22
5. Exploring PLGA-OH-CATH30 Microspheres for Oral Therapy of Escherichia coli-Induced Enteritis;Biomolecules;2024-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3